Cardinal Health CAH is set to report third-quarter fiscal 2026 earnings on April 30. The Zacks Consensus Estimate for sales and earnings is pegged at $62.4 billion and $2.81 per share, respectively. Earnings per share (EPS) estimates for CAH have improved 1 cent to $10.32 for 2026 and 2 cents to $11.59 for 2027 over the past 30 days.

CAH heads into its upcoming fiscal third-quarter 2026 earnings release following a strong first-half finish, marked by broad-based profit growth across all five operating segments, including accelerating momentum in specialty, and continued progress in its GMPD turnaround. Second-quarter performance was driven by robust pharmaceutical demand, expanding contributions from recent acquisitions, and…